Is cervical screening necessary in older women?

Cytopathology

Volumn 12, Issue 6, 2001, Pages 351-353

  Cruickshank, Margaret E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CYTOLOGY; EDITORIAL; FEMALE; HUMAN; MASS SCREENING; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE CERVIX CANCER;

AGE DISTRIBUTION; AGE FACTORS; AGED; DELIVERY OF HEALTH CARE; FEMALE; GERIATRICS; GREAT BRITAIN; HUMANS; MASS SCREENING; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0035780110     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2001.00356.x     Document Type: Editorial

References (15)

1. Patnick J (ed.) NHS Cancer Screening Programmes. Reducing the Risk: Cervical Screening Programme. Sheffield: NHS Cervical Screening Programme, 2000.
2. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM. Epidemiologic evidence showing that human papillomavirus causes most cervical intra-epithelial neoplasia. J Natl Cancer Instit 2000; 85: 958-64.
3. Waddell CA. The influence of the cervix on smear quality. I. An audit of cervical smears taken post-colposcopic management of intra-epithelial neoplasia. Cytopathology 1997; 8: 274-81.
4. Parazzini F, La Vecchia C, Negri E, Franceschi S, Moroni S, Chatenoud L, Boulis G. Case-control study of oestrogen replacement therapy and risk of cervical cancer. BMJ 1997; 315: 85-8.
5. Cruickshank ME, Chambers G, Murray GI, McKenzie L, Donaldson C, Andrew J, Campbell MK, Kitchener HC. HPV Testing: Age Restricted Cervical Screening. Sunderland: British Society for Colposcopy and Cervical Pathology; 1999.
6. Van Wijngaarden WJ, Duncan ID. Rationale for stopping cervical screening in women over 50. BMJ 1993; 306: 967-71.
7. Van Wijngaarden WJ, Duncan ID. Upper age limit for cervical screening. BMJ 1993; 306: 1409-10.
8. McKenzie CA, Duncan ID. The value of cervical screening in women over 50 years of age - Time for a multicentre audit. Scottish Med J 1998; 43: 19-20.
9. Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping cervical screening at age 50. Br J Obstet Gynaecol 1997; 104: 586-9.
10. Sigurdsson K. Trends in cervical intraepithelial neoplasia in Iceland through evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol 1999 1995; 78: 486-92.
11. Andrae B, Smith P. Clinical impact of quality assurance in an organised cervical screening program. Acta Obstetrica Gynecol Scand, 1999; 78: 429-35.
12. Flannelly GM, Monaghan J, Cruickshank ME, Duncan I, Johnson J, Jordan J, Campbell MK, Patnick J. Cervical screening in women over fifty. Can we stop screening? Dublin: First European Congress of Colposcopy and Cervical Pathology; 1998.
13. Forsmo S, Jacobsen BK, Stalsberg H. Cervical neoplasia in pap smears: Risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior pap smears in a population without a mass screening programme. Int J Epidemol 1996; 25: 53-8.
14. Sherlaw-Johnson C, Gallivan S, Jenkins D. Withdrawing low risk women from cervical screening programmes: Mathematical modelling study. BMJ 1999; 318: 356-61.
15. Cruickshank ME, McKenzie L, Donaldson C, Kitchener HC. HPV 16 testing at age 50 as a means of age restricting cervical screening. Dublin: First European Congress of Colposcopy and Cervical Pathology; 1998.